References
- 1. N. D. Gaikwad, S. V. Patil and V. D. Bobade, Synthesis and antimicrobial activity of novel thiazole substituted pyrazole derivatives, J. Het. Chem. 50 (2013) 519-527; DOI: 10.1002/jhet.1513.
- 2. M. S. Essam and M. M. H Nagwa, Synthesis and antimicrobial evaluation of some pyrazole derivatives, Molecules 17 (2012) 4962-4971; DOI: 10.3390/molecules17054962.
- 3. Z. Chuan-Yu, L. Xing-Hai, W. Bao-Lei, W. Su-Hua and L. Zheng-Ming, Synthesis and antifungal activities of new pyrazole derivatives via 1,3-dipolar cycloaddition reaction, Chem. Biol. Drug Des. 75 (2010) 489-493; DOI: 10.1111/j.1747-0285.2010.00948.x.
- 4. E. M. Flefel, W. A. Tantawy, W. A. El-Sayed, H. H. Sayed and N. M. Fathy, Synthesis and anticancer activity of new substituted pyrazoles and their derived 1,2,4-triazoles and sugar derivatives, J. Het. Chem. 50 (2013) 344-350; DOI: 10.1002/jhet.1122.
- 5. S. M. El-Moghazy, F. F. Barsoum, H. M. Abdel-Rahman and A. A. Marzouk, Synthesis and antiinflammatory activity of some pyrazole derivatives, Med. Chem. Res. 21 (2012) 1722-1733; DOI: 10.1007/s00044-011-9691-4.
- 6. M. M. Ghorab, F. A. Ragab, S. I. Alqasoumi, A. M. Alafeefy and S. A. Aboulmagd, Synthesis of some new pyrazolo[3,4-d]pyrimidine derivatives of expected anticancer and radioprotective activity, Eur. J. Med. Chem. 45 (2010) 171-178; DOI: 10.1016/j.bmc.2013.11.042.
- 7. B. Parashar, A. Jain, S. Bharadwaj and V. K. Sharma, Synthesis and pharmacological properties of some novel pyrazolidine and pyrazole derivatives, Med. Chem. Res. 21 (2012) 1692-1699; DOI: 10.1007/s00044-011-9687-0.
- 8. A. B. Adnan, H. Ariaya, A. Henok and E. A. B. Alaa, Synthesis and biological evaluation of some pyrazole derivatives as anti-malarial agents, Arch. Pharm. Chem. Life Sci. 345 (2012) 147-154; DOI: 10.1002/ardp.201100078.
- 9. M. M. Ghorab, H. I. Zienab, A. Mohamad and A. A. Radwan, Synthesis, antimicrobial evaluation and molecular modelling of novel sulfonamides carrying a biologically active quinazoline nucleus, J. Pharm. Res. 36 (2013) 660-670; DOI: 10.1007/s12272-013-0094-6.
- 10. M. M. Ghorab, H. I. Zienab, A. A. Radwan and A. Mohamad, Synthesis and pharmacophore modeling of novel quinazolines bearing a biologically active sulfonamide moiety, Acta Pharm. 63 (2013) 1-18; DOI: 10.2478/acph-2013-0006.
- 11. M. Lindler, W. Sippl and A. A. Radwan, Pharmacophore elucidation and molecular docking studies on 5-phenyl-1-(3-pyridyl)-1H-1,2,4-triazole-3-carboxylic acid derivatives as COX-2 inhibitors, Sci. Pharm. 78 (2010) 195-214; DOI: 10.3797/scipharm.0912-19.
- 12. M. M. Ghorab, F. A. Ragab, H. I. Heiba and M. G. El-Gazzar, Synthesis, in vitro anticancer screening and radiosensitizing evaluation of some new 4-[3-(substituted)thioureido]-N-(quinoxalin-2-yl)- benzenesulfonamide derivatives, Acta Pharm. 61 (2011) 415-425; DOI: 10.2478/v10007-011-0040-4.
- 13. M. M. Ghorab, F. A. Ragab, H. I. Hieba, H. A. Yousef and M. G. El-Gazzar, Synthesis of novel pyrazole and pyrimidine derivatives bearing sulfonamide moiety as antitumor and radiosensitizing agents, Med. Chem. Res. 21 (2012) 1376-1383; DOI 10.1007/s00044-013-0721-2.
- 14. M. S. Al-Dosari, M. M. Ghorab, M. S. Alsaid, Y. M. Nissan and A. B. Ahmed, Synthesis and anticancer activity of some novel trifluoromethylquinolines carrying a biologically active benzenesulfonamide moiety, Eur. J. Med. Chem. 69 (2013) 373-383; DOI: 10.1016/j.ejmech.2013.08.048.
- 15. A. M. Ali, G. E. Saber, N. M. Mahfouz, M. A. El-Gendy, A. A. Radwan and M. A. E. Hamid, Synthesis and three-dimensional qualitative structure selectivity relationship of 3,5-disubstituted-2,4-thiazolidinedion derivatives as COX2 inhibitors, Arch. Pharm. Res. 30 (2007) 1186-1204; DOI: 10.1007/BF02980259.
- 16. M. M. Ghorab and M. S. Alsaid, Synthesis and antitumor activity of some novel hydrazide, 1,2-dihydropyridine, chromene, and benzochromene derivatives, J. Heterocyclic Chem. 49 (2012) 272-280; DOI: 10.1002/jhet.829.
- 17. M. M. Ghorab, F. A. Ragab, H. I. Hieba and W. M. Ghorab, Design and synthesis of some novel quinoline derivatives as anticancer and radiosensitizing agents targeting VEGFR tyrosine kinase, J. Heterocyclic Chem. 48 (2011) 1269-1279; DOI: /10.1002/jhet.749.
- 18. M. M. Ghorab, M. S. Alsaid and E. M. El-Hossary, In vitro cytotoxic evaluation of some new heterocyclic sulfonamide derivatives, J. Heterocyclic Chem. 48 (2011) 563-571; DOI: 10.1002/jhet.619.
- 19. M. Alvarado, G. Pilar, M. Macías-González, F. J. Pavón, A. Serrano, N. Jagerovic, J. Elguero, A. Gutiérrez-Rodríguez, S. García-Granda, M. Suardíaz and F. R. de Fonseca, Antiobesity designed multiple ligands: Synthesis of pyrazole fatty acid amides and evaluation as hypophagic agents, Bioorg. Med. Chem. 16 (2008) 10098-10105; DOI: 10.1016/j.bmc.2008.10.023.
- 20. I. L. Finar and R. J. Hurlock, The skraup reaction with aminopyrazoles, J. Chem. Soc. 1958, 3259-3263; DOI: 10.1039/JR9580003259.
- 21. H. Naeimi, Z. S. Nazifi, S. M. Amininezhad and M. Amouheidari, Synthesis, characterization and in vitro antimicrobial activity of some new Schiff bases and their complexes, J. Antibiot. 66 (2013) 687-689; DOI: 10.1038/ja.2013.73.